Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Otorhinolaryngology

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 96 articles:
HTML format



Single Articles


    April 2020
  1. REN J, Xu W, Su J, Ren X, et al
    Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.
    Int J Cancer. 2020;146:2166-2174.
    PubMed     Abstract available


  2. SIMON J, Schroeder L, Ingarfield K, Diehl S, et al
    Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Int J Cancer. 2020 Apr 12. doi: 10.1002/ijc.33006.
    PubMed     Abstract available


    March 2020
  3. TIAN W, Zhu F, Cai J, Li L, et al
    Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma (NPC) patients in Hunan province, southern China.
    Int J Cancer. 2020 Mar 24. doi: 10.1002/ijc.32992.
    PubMed     Abstract available


  4. ESSERS PBM, van der Heijden M, Vossen D, de Roest RH, et al
    Ovarian cancer derived copy number alterations signatures are prognostic in chemoradiotherapy treated head and neck squamous cell carcinoma.
    Int J Cancer. 2020 Mar 13. doi: 10.1002/ijc.32962.
    PubMed     Abstract available


    February 2020
  5. ZSCHAECK S, Li Y, Butof R, Lili C, et al
    Combined tumor plus non-tumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer.
    Int J Cancer. 2020 Feb 3. doi: 10.1002/ijc.32897.
    PubMed     Abstract available


    January 2020
  6. MASTERSON L, Howard J, Gonzalez-Cruz J, Jackson C, et al
    Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation?
    Int J Cancer. 2020 Jan 17. doi: 10.1002/ijc.32869.
    PubMed     Abstract available


    December 2019
  7. SU TH, Tseng TC, Liu CJ, Chou SW, et al
    Antiviral Therapy against Chronic Hepatitis C is Associated with a Reduced Risk of Oral Cancer.
    Int J Cancer. 2019 Dec 19. doi: 10.1002/ijc.32840.
    PubMed     Abstract available


  8. PALACIOS-GARCIA J, Sanz-Flores M, Asensio A, Alvarado R, et al
    G-protein coupled receptor kinase 2 safeguards epithelial phenotype in Head and Neck Squamous Cell Carcinomas.
    Int J Cancer. 2019 Dec 18. doi: 10.1002/ijc.32838.
    PubMed     Abstract available


  9. WILKAT M, Bast H, Drees R, Dunser J, et al
    Adenosine receptor 2B activity promotes autonomous growth, migration as well as vascularization of head and neck squamous cell carcinoma cells.
    Int J Cancer. 2019 Dec 17. doi: 10.1002/ijc.32835.
    PubMed     Abstract available


  10. CHANG CP, Siwakoti B, Sapkota A, Gautam DK, et al
    Tobacco smoking, chewing habits, alcohol drinking and the risk of head and neck cancer in Nepal.
    Int J Cancer. 2019 Dec 13. doi: 10.1002/ijc.32823.
    PubMed     Abstract available


    November 2019
  11. RYAN N, Anderson K, Volpedo G, Hamza O, et al
    STAT1 inhibits T cell exhaustion and myeloid derived suppressor cell accumulation to promote anti-tumor immune responses in head and neck squamous cell carcinoma.
    Int J Cancer. 2019 Nov 10. doi: 10.1002/ijc.32781.
    PubMed     Abstract available


    October 2019
  12. AVERSA J, Song M, Shimazu T, Inoue M, et al
    Prediagnostic Circulating Inflammation Biomarkers and Esophageal Squamous Cell Carcinoma: A Case-Cohort Study in Japan.
    Int J Cancer. 2019 Oct 31. doi: 10.1002/ijc.32763.
    PubMed     Abstract available


  13. BECKHAM TH, Barney C, Healy E, Wolfe AR, et al
    Platinum-Based Regimens Versus Cetuximab in Definitive Chemoradiation for Human Papillomavirus-Unrelated Head and Neck Cancer.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32736.
    PubMed     Abstract available


  14. LEONG MML, Cheung AKL, Kwok TCT, Lung ML, et al
    Functional Characterization of a Candidate Tumor Suppressor Gene, Mirror Image Polydactyly 1, in Nasopharyngeal Carcinoma.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32732.
    PubMed     Abstract available


  15. MADATHIL S, Rousseau MC, Joseph L, Coutlee F, et al
    Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32708.
    PubMed     Abstract available


    September 2019
  16. KANO M, Kondo S, Wakisaka N, Wakae K, et al
    Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer.
    Int J Cancer. 2019;145:1547-1557.
    PubMed     Abstract available


    August 2019
  17. TAN LP, Tan GW, Sivanesan VM, Goh SL, et al
    Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of Nasopharyngeal Carcinoma.
    Int J Cancer. 2019 Aug 30. doi: 10.1002/ijc.32656.
    PubMed     Abstract available


  18. GANGKOFNER DS, Holzinger D, Schroeder L, Eichmuller SB, et al
    Patterns of antibody responses to non-viral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
    Int J Cancer. 2019 Aug 12. doi: 10.1002/ijc.32623.
    PubMed     Abstract available


  19. KO JM, Ning L, Zhao XK, Chai AW, et al
    BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
    Int J Cancer. 2019 Aug 9. doi: 10.1002/ijc.32619.
    PubMed     Abstract available


    July 2019
  20. ANUSIC T, Gianicolo EAL
    Comment on "A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma" by Islami et al.
    Int J Cancer. 2019 Jul 31. doi: 10.1002/ijc.32601.
    PubMed    


  21. DIJKSTERHUIS WPM, Verhoeven RHA, Slingerland M, Haj Mohammad N, et al
    Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: a real-world evidence study.
    Int J Cancer. 2019 Jul 24. doi: 10.1002/ijc.32580.
    PubMed     Abstract available


  22. GIULIANO AR, Nedjai B, Lorincz AT, Schell MJ, et al
    Methylation Of Hpv 16 And Epb41l3 In Oral Gargles: Associations With Oropharyngeal Cancer Detection And Tumor Characteristics.
    Int J Cancer. 2019 Jul 15. doi: 10.1002/ijc.32570.
    PubMed     Abstract available


  23. DOVEY DE LA COUR C, Dehlendorff C, Aalborg GL, von Buchwald C, et al
    Use of nonaspirin non-steroidal anti-inflammatory drugs and risk of head and neck cancer: a nationwide case-control study.
    Int J Cancer. 2019 Jul 2. doi: 10.1002/ijc.32544.
    PubMed     Abstract available


    May 2019
  24. SCHMITT K, Molfenter B, Koerich Laureano N, Tawk B, et al
    Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
    Int J Cancer. 2019 May 28. doi: 10.1002/ijc.32481.
    PubMed     Abstract available


  25. DOGAN S, Xu B, Middha S, Vanderbilt CM, et al
    Identification of Prognostic Molecular Biomarkers in 157 HPV-positive and HPV-negative Squamous Cell Carcinomas of the Oropharynx.
    Int J Cancer. 2019 May 16. doi: 10.1002/ijc.32412.
    PubMed     Abstract available


  26. RAMAYANTI O, Verkuijlen SAWM, Novianti P, Scheepbouwer C, et al
    Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Int J Cancer. 2019;144:2555-2566.
    PubMed     Abstract available


  27. YOU R, Liu YP, Lin M, Huang PY, et al
    Relationship of Circulating Tumor Cells and Epstein-Barr Virus DNA to Progression-Free Survival and Overall Survival in Metastatic Nasopharyngeal Carcinoma Patients.
    Int J Cancer. 2019 May 1. doi: 10.1002/ijc.32380.
    PubMed     Abstract available


    April 2019
  28. LEE VH, Kwong DL, Leung TW, Choi CW, et al
    The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
    Int J Cancer. 2019;144:1713-1722.
    PubMed     Abstract available


    March 2019
  29. BISWAS NK, Das C, Das S, Maitra A, et al
    Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32305.
    PubMed     Abstract available


  30. LIU CC, Chou KT, Hsu JW, Lin JH, et al
    High metabolic rate and stem cell characteristics of esophageal cancer stem-like cells depend on the Hsp27-AKT-HK2 pathway.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32301.
    PubMed     Abstract available


  31. ISLAMI F, Poustchi H, Pourshams A, Khoshnia M, et al
    A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32220.
    PubMed     Abstract available


  32. LIU X, Song M, Wang P, Zhao R, et al
    Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Int J Cancer. 2019 Mar 18. doi: 10.1002/ijc.32285.
    PubMed     Abstract available


  33. YE F, Gao H, Xiao L, Ding H, et al
    Reply to Cirello et al. "Absence of the MAP2K5 germline variants c.G961A and c. T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families." International Journal of Cancer 2019; in press.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32243.
    PubMed    


  34. CIRELLO V, Colombo C, Persani L, Fugazzola L, et al
    Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32244.
    PubMed    


    January 2019
  35. TAN GW, Sivanesan VM, Abdul Rahman FI, Hassan F, et al
    A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
    Int J Cancer. 2019 Jan 30. doi: 10.1002/ijc.32173.
    PubMed     Abstract available


  36. NOVOPLANSKY O, Fury M, Prasad M, Yegodayev K, et al
    MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32170.
    PubMed     Abstract available


  37. KAWAKITA D, Lee YA, Gren LH, Buys SS, et al
    Fiber Intake and the Risk of Head and Neck Cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32162.
    PubMed     Abstract available


  38. WU C, Nilsson K, Zheng Y, Ekenstierna C, et al
    Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs.
    Int J Cancer. 2019;144:297-310.
    PubMed     Abstract available


  39. AL-SAHAF S, Hunter KD, Bolt R, Ottewell PD, et al
    The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer.
    Int J Cancer. 2019;144:334-344.
    PubMed     Abstract available


  40. LI WF, Chen NY, Zhang N, Hu GQ, et al
    Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
    Int J Cancer. 2019 Jan 6. doi: 10.1002/ijc.32099.
    PubMed     Abstract available


    December 2018
  41. MENYA D, Maina SK, Kibosia C, Kigen N, et al
    Dental fluorosis and oral health in the African Esophageal Cancer Corridor: Findings from the Kenya ESCCAPE case-control study and a pan-African perspective.
    Int J Cancer. 2018 Dec 23. doi: 10.1002/ijc.32086.
    PubMed     Abstract available


  42. GRABER JM, Harris G, Black K, Lucchini RG, et al
    Excess HPV-related head and neck cancer in the World Trade Center Health Program General Responder cohort.
    Int J Cancer. 2018 Dec 17. doi: 10.1002/ijc.32070.
    PubMed     Abstract available


  43. HUI KF, Chan TF, Yang W, Shen JJ, et al
    High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
    Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32049.
    PubMed     Abstract available


    November 2018
  44. MATOBA T, Imai M, Ohkura N, Kawakita D, et al
    Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32024.
    PubMed     Abstract available


  45. ZHANG Y, Tang LL, Li YQ, Liu X, et al
    Spontaneous remission of residual post-therapy plasma Epstein-Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32021.
    PubMed     Abstract available


  46. FENG J, Zhao F, Sun J, Lin B, et al
    Alterations in the Gut Microbiota and Metabolite Profiles of Thyroid Carcinoma Patients.
    Int J Cancer. 2018 Nov 22. doi: 10.1002/ijc.32007.
    PubMed     Abstract available


  47. REN S, Gaykalova D, Wang J, Guo T, et al
    Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2018;143:2425-2436.
    PubMed     Abstract available


  48. SAHNANE N, Ottini G, Turri-Zanoni M, Furlan D, et al
    Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal inverted papilloma to squamous cell carcinoma.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31971.
    PubMed     Abstract available


    October 2018
  49. KASHIMA H, Noma K, Ohara T, Kato T, et al
    Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31953.
    PubMed     Abstract available


  50. HUEBBERS CU, Verhees F, Poluschkin L, Olthof NC, et al
    Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31954.
    PubMed    


  51. CUI M, Hu Y, Bi Y, Wang W, et al
    Preliminary Exploration of Potential Molecular Therapeutic Targets in Recurrent and Metastatic Parathyroid Carcinomas.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31948.
    PubMed     Abstract available


  52. HESARI A, Azizian M, Sheikh A, Nesaei A, et al
    Chemopreventive and therapeutic potential of curcumin in esophageal cancer: current and future status.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31947.
    PubMed     Abstract available


  53. SONG E, Oh HS, Jeon MJ, Chung KW, et al
    The value of preoperative anti-thyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 25. doi: 10.1002/ijc.31944.
    PubMed     Abstract available


  54. JENDRZEJEWSKI J, Liyanarachchi S, Eiterman A, Thomas A, et al
    Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 23. doi: 10.1002/ijc.31933.
    PubMed     Abstract available


  55. HUANG FQ, Li J, Jiang L, Wang FX, et al
    Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 14. doi: 10.1002/ijc.31925.
    PubMed     Abstract available


    September 2018
  56. HUFBAUER M, Maltseva M, Meinrath J, Lechner A, et al
    HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Int J Cancer. 2018;143:1426-1439.
    PubMed     Abstract available


  57. TAO Y, Sturgis EM, Huang Z, Sun Y, et al
    A TGF-beta1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer.
    Int J Cancer. 2018;143:1327-1334.
    PubMed     Abstract available


  58. DUDDING T, Johansson M, Thomas SJ, Brennan P, et al
    Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization.
    Int J Cancer. 2018;143:1029-1036.
    PubMed     Abstract available


    August 2018
  59. KAUPPILA JH, Wahlin K, Lagergren P, Lagergren J, et al
    Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
    Int J Cancer. 2018 Aug 31. doi: 10.1002/ijc.31840.
    PubMed     Abstract available


  60. YE F, Gao H, Xiao L, Zuo Z, et al
    Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
    Int J Cancer. 2018 Aug 22. doi: 10.1002/ijc.31825.
    PubMed     Abstract available


  61. MENYA D, Kigen N, Oduor M, Maina SK, et al
    Traditional and commercial alcohols and esophageal cancer risk in Kenya.
    Int J Cancer. 2018 Aug 17. doi: 10.1002/ijc.31804.
    PubMed     Abstract available


  62. BAO C, Pedersen NL, Yang R, Marseglia A, et al
    Diabetes in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2018;143:793-800.
    PubMed     Abstract available


  63. OCK S, Ahn J, Lee SH, Kim HM, et al
    Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31779.
    PubMed     Abstract available


    July 2018
  64. ROY R, Kandimalla R, Sonohara F, Koike M, et al
    A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31755.
    PubMed     Abstract available


  65. CHEN X, Wang L, Li P, Song M, et al
    Dual TGF-beta and PD-1 blockade synergistically enhances MAGE-A3-specific CD8(+) T cell response in esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31730.
    PubMed     Abstract available


  66. JIANG C, Chen J, Xie S, Zhang L, et al
    Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31642.
    PubMed     Abstract available


  67. PENG SY, Tu HF, Yang CC, Wu CH, et al
    miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31638.
    PubMed     Abstract available


  68. ABRAHAO R, Anantharaman D, Gaborieau V, Abedi-Ardekani B, et al
    The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study.
    Int J Cancer. 2018;143:32-44.
    PubMed     Abstract available


    June 2018
  69. KO JM, Tsang KH, Dai W, Choi SSA, et al
    Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31617.
    PubMed     Abstract available


    April 2018
  70. YU C, Guo Y, Bian Z, Yang L, et al
    Association of low-activity ALDH2 and alcohol consumption with risk of esophageal cancer in Chinese adults: A population-based cohort study.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31566.
    PubMed     Abstract available


  71. MAZUL AL, Shivappa N, Hebert JR, Steck SE, et al
    Proinflammatory diet is associated with increased risk of squamous cell head and neck cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31555.
    PubMed     Abstract available


  72. DENG WW, Li YC, Ma SR, Mao L, et al
    Specific blockade CD73 alters the 'exhausted' phenotype of T cells in head and neck squamous cell carcinoma.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31534.
    PubMed     Abstract available


  73. DENG WW, Li YC, Ma SR, Mao L, et al
    Specific blockade CD73 alters the 'exhausted' phenotype of T cells in head and neck squamous cell carcinoma.
    Int J Cancer. 2018 Apr 12. doi: 10.1002/ijc.31426.
    PubMed     Abstract available


  74. BEYNON RA, Lang S, Schimansky S, Penfold CM, et al
    Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from Head and Neck 5000, a prospective observational cohort of people with head and neck cancer.
    Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31416.
    PubMed    


    March 2018
  75. ARTHUR AE, Goss AM, Demark-Wahnefried W, Mondul AM, et al
    Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: Results from a prospective cohort study.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31413.
    PubMed     Abstract available


  76. ANNUNZIATA C, Pezzuto F, Greggi S, Ionna F, et al
    Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31412.
    PubMed     Abstract available


    February 2018
  77. CHUNG YL, Wu ML
    Spatiotemporal homogeneity and distinctness of the T-cell receptor beta-chain repertoires in Epstein-Barr virus-associated primary and metastatic nasopharyngeal carcinomas.
    Int J Cancer. 2018 Feb 22. doi: 10.1002/ijc.31336.
    PubMed     Abstract available


  78. TER VEER E, Creemers A, de Waal L, van Oijen MGH, et al
    Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31325.
    PubMed     Abstract available


  79. CHAN KKW, Saluja R, Delos Santos K, Lien K, et al
    Neoadjuvant Treatments for Locally Advanced, Resectable Esophageal Cancer: A Network Meta-Analysis.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31312.
    PubMed     Abstract available


  80. RIETBERGEN MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, et al
    Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31315.
    PubMed     Abstract available


    January 2018
  81. WANG YQ, Chen YP, Zhang Y, Jiang W, et al
    Prognostic significance of tumor-infiltrating lymphocytes in non-disseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Int J Cancer. 2018 Jan 27. doi: 10.1002/ijc.31279.
    PubMed     Abstract available


  82. LEEMAN JE, McBride SM, Spielsinger D, Sherman EJ, et al
    Head and Neck Cancers Associated with Exposure to the September 11, 2001 World Trade Center Terrorist Attacks.
    Int J Cancer. 2018 Jan 25. doi: 10.1002/ijc.31277.
    PubMed     Abstract available


  83. MERMOD M, Hiou-Feige A, Bovay E, Roh V, et al
    Mouse model of post-surgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer.
    Int J Cancer. 2018 Jan 4. doi: 10.1002/ijc.31240.
    PubMed     Abstract available


    December 2017
  84. SIEW SS, Martinsen JI, Kjaerheim K, Sparen P, et al
    Occupational exposure to wood dust and risk of nasal and nasopharyngeal cancer: A case-control study among men in four nordic countries-With an emphasis on nasal adenocarcinoma.
    Int J Cancer. 2017;141:2430-2436.
    PubMed     Abstract available


  85. STANGL S, Tontcheva N, Sievert W, Shevtsov M, et al
    Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31213.
    PubMed     Abstract available


    November 2017
  86. DOSSUS L, Franceschi S, Biessy C, Navionis AS, et al
    Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
    Int J Cancer. 2017 Nov 23. doi: 10.1002/ijc.31172.
    PubMed     Abstract available


  87. YUNHONG T, Jie L, Yunming T, Guoqian Z, et al
    Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    Int J Cancer. 2017 Nov 16. doi: 10.1002/ijc.31157.
    PubMed     Abstract available


  88. HU J, Li H, Luo X, Li Y, et al
    The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.
    Int J Cancer. 2017;141:1722-1729.
    PubMed     Abstract available


    October 2017
  89. MAO L, Zhao ZL, Yu GT, Wu L, et al
    gamma-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31115.
    PubMed     Abstract available


  90. HOFFMANN M, Pasch S, Schamberger T, Maneck M, et al
    Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31108.
    PubMed     Abstract available


  91. ZHU L, Sturgis EM, Zhang H, Lu Z, et al
    Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Int J Cancer. 2017;141:1355-1364.
    PubMed     Abstract available


    September 2017
  92. KLINGHAMMER K, Keller J, George J, Hoffmann J, et al
    A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31045.
    PubMed     Abstract available


  93. LIU J, Lv L, Gong J, Tan Y, et al
    Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38alpha- and JNK-mediated apoptosis in esophageal squamous cell carcinoma.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31040.
    PubMed     Abstract available


    August 2017
  94. SHIVAPPA N, Hebert JR, Rosato V, Garavello W, et al
    Inflammatory potential of diet and risk of oral and pharyngeal cancer in a large case-control study from Italy.
    Int J Cancer. 2017;141:471-479.
    PubMed     Abstract available


    June 2017
  95. HOLZINGER D, Wichmann G, Baboci L, Michel A, et al
    Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2017;140:2748-2757.
    PubMed     Abstract available


    April 2017
  96. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: